U

University of New Mexico Health Sciences Center | UNM Cancer Center Clinical Research Office/NMCCA

Research site
(Unclaimed)
Location
1201 Camino de Salud Northeast, Albuquerque, New Mexico, United States of America

Site insights

Top conditions

Top treatments

Treprostinil
Psilocybin
Ritlecitinib
ADX48621
Nalmefene
Fesoterodine
Methadone
Bevacizumab
Seralutinib
Metformin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 72 total trials

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents with Nonsegmental Vitiligo (Active and Stable) Tranquillo

Enrolling
Stable Nonsegmental Vitiligo
Active Nonsegmental Vitiligo
Drug: Ritlecitinib
Drug: Placebo

This study is designed to evaluate the safety and efficacy of dipraglurant in PD patients with dyskinesia (randomized 1:1 to receive active or placeb...

Enrolling
Parkinson Disease
Dyskinesia, Drug-Induced
Drug: Dipraglurant
Drug: Placebo

The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are...

Enrolling
Pulmonary Arterial Hypertension
Drug: Placebo
Drug: Seralutinib

Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.

Invitation-only
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Device: Treprostinil Ultrasonic Nebulizer
Drug: Inhaled Treprostinil

The goal of this clinical trial is to test the effectiveness of an integrated infectious disease/substance use disorder (SUD) clinical team intervent...

Enrolling
Substance Use Disorders
Injection Site Infection
Behavioral: Treatment as Usual
Behavioral: SIRI Team

This trial will be a randomized controlled single-center pilot trial comparing the use of angiotensin II versus standard-of-care (SOC) vasopressor th...

Enrolling
Vasodilatory Shock
Septic Shock
Drug: Angiotensin II

Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FV...

Enrolling
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Drug: Inhaled Treprostinil
Drug: Placebo

Trial sponsors

University of New Mexico (UNM) logo
NYU Langone Health logo
I
Johns Hopkins University logo
United Therapeutics logo
Gilead Sciences logo
Pfizer logo
University of California San Francisco (UCSF) logo
Vanderbilt University Medical Center logo
Abbott logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems